KP Tissue Inc. (TSE:KPT – Get Free Report) shares passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of C$11.57 and traded as high as C$12.91. KP Tissue shares last traded at C$12.90, with a volume of 22,953 shares changing hands.
Wall Street Analysts Forecast Growth
Several analysts recently commented on the stock. Desjardins raised their price target on shares of KP Tissue from C$12.00 to C$12.50 and gave the stock a “hold” rating in a report on Friday, May 15th. TD upped their price objective on shares of KP Tissue from C$12.00 to C$14.00 and gave the company a “hold” rating in a research note on Tuesday, July 14th. Three equities research analysts have rated the stock with a Hold rating, Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of C$12.12.
Read Our Latest Stock Report on KP Tissue
KP Tissue Stock Up 0.2%
KP Tissue (TSE:KPT – Get Free Report) last issued its earnings results on Thursday, May 14th. The company reported C$0.22 earnings per share for the quarter. Equities analysts anticipate that KP Tissue Inc. will post 0.4398964 earnings per share for the current year.
KP Tissue Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Wednesday, July 15th. Investors of record on Wednesday, July 15th were paid a $0.21 dividend. The ex-dividend date of this dividend was Tuesday, June 30th. This represents a $0.84 annualized dividend and a dividend yield of 6.5%. KP Tissue’s payout ratio is presently 80.00%.
Insider Buying and Selling
In related news, Director David A. Spraley sold 3,668 shares of the stock in a transaction that occurred on Wednesday, June 17th. The stock was sold at an average price of C$13.30, for a total value of C$48,784.40. Following the transaction, the director owned 15,712 shares in the company, valued at approximately C$208,969.60. This represents a 18.93% decrease in their ownership of the stock. Insiders sold a total of 6,668 shares of company stock valued at $87,644 in the last 90 days. Corporate insiders own 0.14% of the company’s stock.
KP Tissue Company Profile
KPT was created to acquire, and its business is limited to holding, a limited equity interest in Kruger Products, which is accounted for as an investment on the equity basis. KPT currently holds a 12% interest in Kruger Products.
Further Reading
- Five stocks we like better than KP Tissue
- Chevron’s Strong Quarter Shows Why It Still Leads the Energy Sector
- Amazon’s Earnings Beat Shows Why AWS Is Back at the Center of the Bull Case
- Apple’s Record Quarter Could Not Outrun Its Guidance Problem
- McKesson’s Compounding Keeps Adding Up
Receive News & Ratings for KP Tissue Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KP Tissue and related companies with MarketBeat.com's FREE daily email newsletter.
